Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006; 8(2):R15.
View in:
PubMed
subject areas
Abortion, Spontaneous
Abortion, Therapeutic
Breast Neoplasms
Case-Control Studies
Female
Genes, BRCA1
Genes, BRCA2
Genetic Carrier Screening
Humans
Mutation
Pregnancy
Risk Assessment
Risk Factors
authors with profiles
Olufunmilayo Olopade